Abstract
The authors describe the use of gabapentin in the treatment of 4 outpatients with dementia-associated agitation. On the basis of clinical case reports and the Overt Agitation Severity Scale, all 4 patients had reduced agitation with gabapentin. Three of 4 patients were successfully titrated to a full dose of 2,400 mg/day. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia.
Original language | English |
---|---|
Pages (from-to) | 40-43 |
Number of pages | 4 |
Journal | Journal of Neuropsychiatry and Clinical Neurosciences |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - 2000 |
Externally published | Yes |